vs
N-able, Inc.（NABL）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
N-able, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.9倍（$130.3M vs $69.8M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 11.8%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 7.0%）
Able UK是一家英国工业服务企业，主打船舶与海上设施的退役拆解业务，深耕该领域多年，具备大型工业设施拆除作业的专业能力与丰富经验，在英国相关工业服务市场占据一席之地。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NABL vs RIGL — 直观对比
营收规模更大
NABL
是对方的1.9倍
$69.8M
营收增速更快
RIGL
高出9.4%
11.8%
两年增速更快
RIGL
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $130.3M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | 76.2% | 91.5% |
| 营业利润率 | 10.2% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | 11.8% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $-0.04 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NABLRIGL
| Q4 25 | $130.3M | $69.8M | ||
| Q3 25 | $131.7M | $69.5M | ||
| Q2 25 | $131.2M | $101.7M | ||
| Q1 25 | $118.2M | $53.3M | ||
| Q4 24 | $116.5M | $57.6M | ||
| Q3 24 | $116.4M | $55.3M | ||
| Q2 24 | $119.4M | $36.8M | ||
| Q1 24 | $113.7M | $29.5M |
净利润NABLRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $1.4M | $27.9M | ||
| Q2 25 | $-4.0M | $59.6M | ||
| Q1 25 | $-7.2M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $10.8M | $12.4M | ||
| Q2 24 | $9.5M | $-1.0M | ||
| Q1 24 | $7.5M | $-8.2M |
毛利率NABLRIGL
| Q4 25 | 76.2% | 91.5% | ||
| Q3 25 | 77.5% | 93.2% | ||
| Q2 25 | 78.1% | 95.6% | ||
| Q1 25 | 76.6% | 91.7% | ||
| Q4 24 | 80.0% | 89.9% | ||
| Q3 24 | 82.9% | 85.5% | ||
| Q2 24 | 84.0% | 92.4% | ||
| Q1 24 | 83.9% | 93.1% |
营业利润率NABLRIGL
| Q4 25 | 10.2% | 33.2% | ||
| Q3 25 | 8.8% | 40.9% | ||
| Q2 25 | 7.7% | 60.1% | ||
| Q1 25 | 1.5% | 23.9% | ||
| Q4 24 | 13.7% | 28.9% | ||
| Q3 24 | 20.5% | 25.4% | ||
| Q2 24 | 18.4% | 1.2% | ||
| Q1 24 | 18.0% | -23.6% |
净利率NABLRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 1.1% | 40.2% | ||
| Q2 25 | -3.1% | 58.6% | ||
| Q1 25 | -6.1% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 9.2% | 22.5% | ||
| Q2 24 | 7.9% | -2.8% | ||
| Q1 24 | 6.6% | -27.9% |
每股收益（稀释后）NABLRIGL
| Q4 25 | $-0.04 | $14.11 | ||
| Q3 25 | $0.01 | $1.46 | ||
| Q2 25 | $-0.02 | $3.28 | ||
| Q1 25 | $-0.04 | $0.63 | ||
| Q4 24 | $0.01 | $0.82 | ||
| Q3 24 | $0.06 | $0.70 | ||
| Q2 24 | $0.05 | $-0.06 | ||
| Q1 24 | $0.04 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $111.8M | $155.0M |
| 总债务越低越好 | $393.9M | $52.5M |
| 股东权益账面价值 | $804.7M | $391.5M |
| 总资产 | $1.4B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.49× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NABLRIGL
| Q4 25 | $111.8M | $155.0M | ||
| Q3 25 | $101.4M | $137.1M | ||
| Q2 25 | $93.9M | $108.4M | ||
| Q1 25 | $94.1M | $77.1M | ||
| Q4 24 | $85.2M | $77.3M | ||
| Q3 24 | $174.4M | $61.1M | ||
| Q2 24 | $157.5M | $49.1M | ||
| Q1 24 | $139.2M | $49.5M |
总债务NABLRIGL
| Q4 25 | $393.9M | $52.5M | ||
| Q3 25 | $331.7M | $60.0M | ||
| Q2 25 | $332.1M | $60.0M | ||
| Q1 25 | $332.6M | $60.0M | ||
| Q4 24 | $333.1M | $60.0M | ||
| Q3 24 | $333.6M | $60.0M | ||
| Q2 24 | $334.1M | $60.0M | ||
| Q1 24 | $334.5M | $60.0M |
股东权益NABLRIGL
| Q4 25 | $804.7M | $391.5M | ||
| Q3 25 | $813.4M | $117.6M | ||
| Q2 25 | $809.4M | $81.9M | ||
| Q1 25 | $775.1M | $18.6M | ||
| Q4 24 | $759.3M | $3.3M | ||
| Q3 24 | $765.0M | $-14.6M | ||
| Q2 24 | $724.4M | $-29.9M | ||
| Q1 24 | $709.1M | $-31.7M |
总资产NABLRIGL
| Q4 25 | $1.4B | $513.6M | ||
| Q3 25 | $1.4B | $242.5M | ||
| Q2 25 | $1.4B | $206.7M | ||
| Q1 25 | $1.4B | $176.0M | ||
| Q4 24 | $1.3B | $164.0M | ||
| Q3 24 | $1.2B | $139.4M | ||
| Q2 24 | $1.2B | $128.4M | ||
| Q1 24 | $1.1B | $126.5M |
负债/权益比NABLRIGL
| Q4 25 | 0.49× | 0.13× | ||
| Q3 25 | 0.41× | 0.51× | ||
| Q2 25 | 0.41× | 0.73× | ||
| Q1 25 | 0.43× | 3.23× | ||
| Q4 24 | 0.44× | 18.25× | ||
| Q3 24 | 0.44× | — | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.47× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.3M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $20.9M | — |
| 自由现金流率自由现金流/营收 | 16.0% | — |
| 资本支出强度资本支出/营收 | 3.4% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $75.1M | — |
8季度趋势，按日历期对齐
经营现金流NABLRIGL
| Q4 25 | $25.3M | $22.0M | ||
| Q3 25 | $24.0M | $24.0M | ||
| Q2 25 | $24.2M | $30.5M | ||
| Q1 25 | $19.7M | $-893.0K | ||
| Q4 24 | $26.0M | $14.5M | ||
| Q3 24 | $22.0M | $21.7M | ||
| Q2 24 | $27.3M | $302.0K | ||
| Q1 24 | $4.2M | $-5.0M |
自由现金流NABLRIGL
| Q4 25 | $20.9M | — | ||
| Q3 25 | $17.4M | — | ||
| Q2 25 | $20.4M | — | ||
| Q1 25 | $16.4M | — | ||
| Q4 24 | $18.8M | — | ||
| Q3 24 | $18.2M | — | ||
| Q2 24 | $24.0M | — | ||
| Q1 24 | $746.0K | — |
自由现金流率NABLRIGL
| Q4 25 | 16.0% | — | ||
| Q3 25 | 13.2% | — | ||
| Q2 25 | 15.5% | — | ||
| Q1 25 | 13.9% | — | ||
| Q4 24 | 16.2% | — | ||
| Q3 24 | 15.7% | — | ||
| Q2 24 | 20.1% | — | ||
| Q1 24 | 0.7% | — |
资本支出强度NABLRIGL
| Q4 25 | 3.4% | — | ||
| Q3 25 | 5.0% | — | ||
| Q2 25 | 2.9% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 3.0% | — |
现金转化率NABLRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 17.36× | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 2.04× | 1.75× | ||
| Q2 24 | 2.89× | — | ||
| Q1 24 | 0.56× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NABL
| Transferred Over Time | $121.9M | 94% |
| Transferred At Point In Time | $8.4M | 6% |
| Other Revenue | $1.3M | 1% |
RIGL
暂无分部数据
